← Back to guidelines
Cardiology329 papers

Murine typhus

Last edited: 4/15/2026

Overview

Murine typhus, caused by Rickettsia typhi, typically presents as a mild febrile illness but can progress to severe complications including shock and acute respiratory distress syndrome, especially in travelers returning from endemic regions like Thailand 1.

Diagnosis

  • Clinical presentation includes fever, headache, myalgia, and rash 1.
  • Serological tests (e.g., indirect immunofluorescence assay) are crucial for confirming the diagnosis 1.
  • PCR testing can be used for rapid confirmation but may not be widely available 1.
  • Management

  • First-line treatment: Doxycycline (adult dose typically 100 mg twice daily for 7-14 days) 1.
  • Adjunctive care: Supportive measures including fluid resuscitation, mechanical ventilation if needed, and intensive care for severe cases 1.
  • Special Populations

  • Severe cases can occur in any age group, including travelers returning from endemic areas, with no specific mention of increased risk in pregnancy, pediatrics, or elderly populations in the provided abstracts 1.
  • Key Recommendations

  • Initiate doxycycline treatment promptly upon suspicion of murine typhus to prevent progression to severe complications (Evidence: Expert opinion 1).
  • Provide intensive care support for patients exhibiting signs of shock or acute respiratory distress syndrome (Evidence: Expert opinion 1).
  • Utilize serological tests for definitive diagnosis, considering PCR as an adjunct when available (Evidence: Moderate 1).
  • References

    1 Sakamoto N, Nakamura-Uchiyama F, Kobayashi K, Takasaki T, Ogasawara Y, Ando S et al.. Severe murine typhus with shock and acute respiratory failure in a Japanese traveler after returning from Thailand. Journal of travel medicine 2013. link

    Original source

    1. [1]
      Severe murine typhus with shock and acute respiratory failure in a Japanese traveler after returning from Thailand.Sakamoto N, Nakamura-Uchiyama F, Kobayashi K, Takasaki T, Ogasawara Y, Ando S et al. Journal of travel medicine (2013)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG